Related Experiment Videos
Effects of aerosolized methylprednisolone on experimental neurogenic pulmonary injury
Abstract:
We examined the effects of graded doses of methylprednisolone sodium succinate (MPSS)--0.05 (low), 0.5 (medium), and 5 mg/kg/hour (high)--on the development of neurogenic pulmonary injury in rabbits. The aerosolized drug was administered intratracheally for 5 hours beginning 10 minutes after a 2-minute elevation of the cerebrospinal fluid pressure (Pcsf) to 250 mm Hg. Compared to untreated control animals, the percentage of increase in pulmonary capillary permeability, as determined by 51Cr-labeled ethylenediaminetetraacetic acid clearance, was significantly less in the low and high dose MPSS groups. However, high dose MPSS was also associated with a significant decrease in compliance and increase in tissue hemorrhage (quantified by visual inspection). These results indicate biphasic effect of MPSS on alveolar capillary integrity after elevated Pcsf. The low dose minimized the extent of lung hemorrhage, pulmonary capillary leakage, and loss of lung compliance. In contrast, the high dose accelerated tissue hemorrhage and compliance loss, even though pulmonary capillary permeability was maintained near base line rates.
Insights
Methylprednisolone sodium succinate (MPSS) shows a biphasic effect on lung injury. Low doses protect pulmonary capillaries, while high doses worsen lung damage and reduce compliance.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Critical Care Medicine
Background:
- Neurogenic pulmonary injury can result from elevated cerebrospinal fluid pressure (Pcsf).
- Methylprednisolone sodium succinate (MPSS) is a corticosteroid with anti-inflammatory properties.
- Understanding MPSS's dose-dependent effects on lung injury is crucial for treatment.
Purpose of the Study:
- To investigate the dose-dependent effects of MPSS on neurogenic pulmonary injury in a rabbit model.
- To evaluate MPSS's impact on pulmonary capillary permeability, lung compliance, and hemorrhage.
Main Methods:
- Rabbits were subjected to elevated Pcsf to induce neurogenic pulmonary injury.
- Aerosolized MPSS at low (0.05 mg/kg/hr), medium (0.5 mg/kg/hr), and high (5 mg/kg/hr) doses were administered intratracheally.
- Pulmonary capillary permeability was assessed using 51Cr-labeled ethylenediaminetetraacetic acid clearance.
- Lung compliance and tissue hemorrhage were quantified.
Main Results:
- Low and high doses of MPSS significantly reduced pulmonary capillary permeability compared to controls.
- High-dose MPSS was associated with a significant decrease in lung compliance and increased tissue hemorrhage.
- Low-dose MPSS minimized lung hemorrhage, capillary leakage, and loss of lung compliance.
Conclusions:
- MPSS exhibits a biphasic effect on alveolar capillary integrity following elevated Pcsf.
- Low-dose MPSS demonstrates protective effects against neurogenic pulmonary injury.
- High-dose MPSS exacerbates lung hemorrhage and compliance loss, despite maintaining capillary permeability.